Background: Safety climate evaluation is increasingly used by hospitals as part of quality improvement initiatives. Consequently, it is necessary to have validated tools to measure changes. Objective: To evaluate the construct validity and internal consistency of a survey tool to measure Australian hospital pharmacy patient safety climate. Methods: A 42 item cross-sectional survey was used to evaluate the patient safety climate of 607 Australian hospital pharmacy staff. Survey responses were initially mapped to the factor structure previously identified in European community pharmacy. However, as the data did not adequately fit the community pharmacy model, participants were randomly split into two groups with exploratory factor analysis performed on the first group (n ¼ 302) and confirmatory factor analyses performed on the second group (n ¼ 305). Results: Following exploratory factor analysis (59.3% variance explained) and confirmatory factor analysis, a 6-factor model containing 28 items was obtained with satisfactory model and working conditions) were similar to those identified in European community pharmacy and labelled identically. Three additional factors (preoccupation with improvement; comfort to question authority; and safety issues being swept under the carpet) highlight hierarchical issues present in hospital settings.
Introduction
Since the publication of the seminal reports To Err is Human: Building a Safer Health System 1 in the United States of America and
An organisation with a memory 2 in the United Kingdom, deficiencies in the delivery of healthcare have received greater attention globally. In Australia, the publication of the Second National Report on Patient Safety: Improving Medication Safety in 2002 raised a number of issues relating specifically to medication safety. Subsequently, there has been a considerable effort to improve both patient and medication safety by healthcare institutions globally. As a result, healthcare institutions have been identifying strategies to evaluate improvements to patient safety, both at the level of the patient and also the healthcare practitioner.
One of the greatest barriers to improving patient safety in hospitals is the safety culture of the organisation. Safety culture is a broad term that encompasses the norms, values, beliefs and assumptions of an organisation. 3, 4 The literature shows that by understanding and improving safety culture, better patient outcomes and healthcare experiences can be achieved. 5 Whilst evaluating safety culture is ideal, using a multilevel ethnographic approach can be logistically challenging and time consuming to accurately perform. 3, 6 Consequently, safety climate is often used to evaluate the safety culture of an organisation, and specifically refers to the employees' perceptions of the safety culture of an organisation at a particular point in time. 6, 7 As part of their role and responsibilities, many hospital pharmacists either drive or engage in medication safety initiatives. However, a number of factors, including working conditions and culture, can affect the safe delivery of care by hospital pharmacists. Currently there are numerous tools that measure safety climate in hospitals, 4 however, due to different perceptions of safety culture across disciplines and practice settings, it is important that any tool used is validated in the target population. 5 Although previous studies have validated safety climate assessment tools for use among community pharmacists in Europe 7 and more recently in hospital pharmacies in Asia, 8, 9 no tool has been validated to measure the patient safety attitudes and values of Australian hospital pharmacists. 10 As the roles and responsibilities and remuneration structure of hospital pharmacies are somewhat different to that of community pharmacists and vary between countries, there is a need for a tool that is able to specifically assess the safety climate of Australian hospital pharmacists. 6, 8 In the absence of a survey tool to measure safety culture in a target population, it is recommended that a survey tool that has been previously used in a population with similar characteristics be used as a basis for studying the target population. 11 Given that the most widely used survey tool to measure safety climate in pharmacists is the Pharmacy Safety Climate Questionnaire which has been previously validated in community pharmacy in the United Kingdom and Europe, this study aimed to evaluate the construct validity of the survey to assess patient safety climate among Australian hospital pharmacy staff.
Methods
A cross-sectional survey was conducted among 2347 hospital pharmacy staff members who were registered as currently practising members of The Society of Hospital Pharmacists of Australia (SHPA), the national professional organisation representing pharmacy staff that work in hospital settings. Data were collected between May and July 2010 with approval to conduct this study granted by the Human Research Ethics Committee at The University of Sydney (Project Number: 12615).
Survey instrument
A survey tool was developed to evaluate the safety climate attitudes of Australian hospital pharmacy staff. The tool was based on the Pharmacy Safety Climate Questionnaire, originally developed to evaluate safety climate in community pharmacy in the United Kingdom, and subsequently validated across a number of other European countries. The tool was modified slightly for use in this study: specifically, three items that referred to similar issues were split into separate items in order to avoid any potential ambiguity in the interpretation of the items by survey respondents. The modified survey tool was reviewed by a small group of practicing hospital pharmacists for face validity. The final survey tool consisted of four sections: (A) a single question assessing overall grade of patient safety in the respondent's hospital pharmacy; (B) 42 Likert-type scale items adapted from the original Pharmacy Safety Climate Questionnaire 12 ; (C) participant and hospital demographics and (D) a free text comment field to provide comments on patient safety, error management and incident reporting. This study relates to the quantitative data collected in sections B and C of the survey. Analysis of the qualitative responses in section D has also been performed, 13 however is not reported here.
Data collection
The federal secretariat of the SHPA granted permission to use the contact details of its members for the purpose of recruitment, in accordance with the SHPA privacy policy. An external data management company was employed to administer the survey on behalf of the research team. All 2347 currently practising SHPA members were sent a letter inviting them to complete the survey. Reply paid envelopes were provided and coded for the members' identities by the data management company, which enabled follow-up of non-responders after 3 weeks. After a total of 10 weeks, the survey was closed and the compiled, de-identified data were provided to the research team.
Data analysis
All data analyses were completed using IBM SPSS Statistics version 21 (SPSS Inc., Chicago, IL) and Amos Version 21 (Amos Development Corporation, Meadville, PA). Expectation maximisation imputation of missing values was conducted as there were a limited number of cases with missing data (n ¼ 10, 1.55%) and the data were considered to be missing at random (Little's MCAR ¼ 2059.71, df ¼ 2064, p ¼ 0.52). Due to the limitations of Amos programming, Mahalanobis distance was calculated to remove multivariate outliers from the cohort. The four factor structure to measure European community pharmacists' safety climate suggested by Phipps et al. 7 was applied to the data. As the goodness of fit statistics were not deemed to be acceptable (c
was concluded that the European community pharmacist model was not appropriate to be applied in the Australian hospital pharmacy setting. Therefore, a two-step process consisting of exploratory and confirmatory factor analyses was undertaken to evaluate the construct validity and internal consistency of the survey tool. Participant responses were randomly split into two groups using the "select cases" function in SPSS with approximately 50% of participants in each group (n ¼ 302 and n ¼ 305). Participant characteristics were compared across the two groups using the independent samples Mann Whitney U test for categorical variables and independent sample t-tests for continuous variables.
An exploratory factor analysis (EFA) was performed on survey responses from the first group of participants to understand the latent structure underpinning their responses to the survey using maximum likelihood estimation and varimax rotation. As adequate sample sizes across both groups were obtained, Kaisers criterion for factor retention was adopted with individual factors loading greater than 0.32 considered significant for retention.
14 The factor structure was assessed for a theoretical basis, using the Scree plot to verify the number of factors retained. The construct validity of the survey was evaluated using a confirmatory factor analysis (CFA) on the second group's survey responses. Each item was considered to have a latent construct and a measurement error, with both causal effects depicted by unidirectional arrows. Correlations between variables within the model were depicted using bi-directional arrows. Maximum likelihood estimation was performed to calculate item loading. Items were removed from the model where modification indices suggested multiple correlations with other items. Using Bentler's method of estimating a minimum sample size to conduct a CFA, which is based on the number of included items to number of factors ratio, it was estimated that 150 survey responses would be adequate. 15 The goodness of fit of the model was evaluated using:
Chi square to measure model parsimony, root mean-square error of approximation (RMSEA) to measure absolute fit, and both the Comparative Fit Index (CFI) and Tucker Lewis Index (TLI) to evaluate the comparative fit. 16 
Results

Participant characteristics
A total of 643 pharmacy staff members completed the survey, representing 27.4% of all SHPA members. Survey responses for 36 pharmacy staff were removed during cleaning of the data due to multivariate non-normality. The remaining 607 pharmacy staff were randomly assigned to two groups, on which the EFA (n ¼ 302) and CFA (n ¼ 305) was performed. The characteristics of both groups of participants are compared in Table 1 and are reflective of those reported in the 2010 workforce snapshot of Australian hospital pharmacists. 17 As there were no significant differences between the two groups, it was deemed satisfactory that both an EFA and CFA could be performed.
Exploratory factor analysis
Following the removal of 11 items, either due to low communalities, less than 0.2 (Table A1) , or low factor loading (less than 0.35), a six factor solution was determined (Table 2 ) with the Kaiser-Meyer-Olkin measure verifying sampling adequacy (KMO ¼ 0.90). This solution explained 59.29% of the variance. Only one item cross-loaded and was assigned to a single factor based on a combination of factor loading and theoretical reasoning. The six factors were labelled as being: (1) blame culture, containing items related to blaming individuals; (2) organisational learning, containing items related to learning and improving from errors; (3) preoccupation with improvement, containing items about assessing risks and improvements; (4) working conditions, containing items related to the quantity of work and time that affect safety; (5) comfort to question authority, containing items about questioning the decisions and actions of those with more authority; and (6) safety issues are swept under the carpet, containing items about ignoring incidents and complaints.
Confirmatory factor analysis
During the second phase of the analysis, the construct validity of the survey was established through CFA. After mapping the responses from the second group of respondents to the model determined by the EFA, model fit was assessed. 
Discussion
This study has examined the construct validity of a modified version of an existing patient safety climate tool, the Pharmacy Safety Climate Questionnaire, in the Australian hospital pharmacy setting. This is the first time that a survey tool has been validated to measure the patient safety attitudes and values of Australian hospital pharmacy staff members. This is particularly important as hospital pharmacists account for a large proportion of the pharmacy workforce in Australia (17.6%) 17 and the practice model is quite different to that of community pharmacists. 18 This study builds upon the work of Phipps et al., 7 who validated the Pharmacy Safety Climate Questionnaire among European community pharmacy staff and proposed a 4 factor model to explain safety climate that consisted of 24 items. Conversely, in this study a 6 factor model consisting of 28 items was identified to explain safety climate in hospital pharmacy staff. Notably, there were some key similarities between the two models, with three of the factors (blame culture, organisational learning and working conditions) having many of the same items loading, and therefore, were labelled identically to those in the Phipps et al. study. 7 This highlights that blame culture, organisational learning and the working conditions that pharmacists are subject to, are also major issues in hospital pharmacy settings. Further work is required to understand the exact relationship between these three domains. Three new domains were also identified to be important in explaining safety climate in this study: preoccupation with improvement; comfort to question authority and; safety issues being swept under the carpet. In addition to the preparation and supply of medicines, hospital pharmacists are required to undertake a number of other activities as part of their roles and responsibilities. These include performing medication chart reviews, discharge planning and working closely with other healthcare professionals to ensure the quality or rational use of medicines for each patient. However, factors such as the workplace culture of the hospital and the inherent hierarchies that exist within the medical profession can limit the effective fulfilment of these duties. Although these are also issues that have been identified in community pharmacy practice, they are more prominent in hospital practice, 19 which may explain why these factors have arisen. Whilst hierarchies have been shown to have some benefits to improving patient safety, particularly in community settings, 20 in hospital settings, hierarchies have been identified as a major issue that affects the safety culture of the institution. 21, 22 Furthermore, it has been shown that it is difficult for both allied health and junior medical staff to overcome the medical hierarchy and that those at the senior levels of the hierarchy rarely report or talk about errors. 21, 23, 24 Notably, previous studies have shown that improvements to patient outcomes and adverse event reporting occur when junior medical and allied health staff speak up and raise concerns about potential or actual patient safety problems. 23, 25 For this reason, patient safety education curricula and continuing professional development courses are being updated to included specific teamwork and communication training to enable both current and the future generations of health care practitioners to better mitigate hierarchical issues. 26, 27 This survey can therefore be used to evaluate the effectiveness of these programs through the administration of the survey at repeated intervals and evaluating changes in factor scores towards pharmacy staff's preoccupation with improvement; their comfort to question authority; and whether they perceive safety issues are being swept under the carpet. The one factor from the European community pharmacy study that did not arise in our model was "safety focus". In the European community pharmacy study, this factor encompassed questions relating to pharmacists' commitment to patient safety and their attitudes towards patient safety education and training. Although elements of the "safety focus" factor from the previous study were also measured in the "organisational learning" and "preoccupation with improvement" factors in this study, there are two possible reasons why this may be the case. Firstly, this may be due to the context in which the survey was used. The original tool had been validated in a primary care setting in the United Kingdom and Europe, whereas in this study, the survey has been applied to hospital settings in Australia. In addition, this factor may not have arisen due to the sample that was surveyed. In a recent exploratory study of hospital pharmacy safety culture in Australia, it was identified that pharmacy staff members who had memberships with professional organisations responded more positively to the survey items. 10, 18 As our sample was derived from members of the SHPA, this may have potentially affected the "safety focus" factor from the European community pharmacy study emerging, particularly as this factor evaluated negative patient safety attitudes and behaviours. This validation study of the Pharmacy Safety Climate Questionnaire has provided a model for evaluating safety climate in Australian hospital pharmacy staff. Repeated administration of the survey tool in the future will enable the evaluation of changes to safety culture over time. This is particularly important due to the changes to hospital pharmacy practice that were introduced in the years following data collection, including increased pharmacist numbers in hospitals and changes to accreditation schemes to include a specific standard on medication safety, highlighting the important role of pharmacy in ensuring patient safety. Repeated administration could also be used to evaluate the impact of increased patient safety education during pharmacy degree programs has had on the safety climate of hospital pharmacy departments. 28 Furthermore, triangulation of survey data with other safety assessment methods could potentially allow for more comprehensive safety climate interventions to be performed.
Strengths and limitations
This validation study had a number of strengths. Firstly, this study utilised a survey tool that has been previously validated among community pharmacy staff in both the United Kingdom and Western Europe and has been used as part of other larger surveys in evaluating stress and risky behaviours. 7,12,29e31 In addition, a large sample size was obtained that allowed for the dataset to be split and a robust method of both an exploratory and confirmatory factor analysis to be performed, with acceptable model fit achieved. Furthermore, the characteristics of the sample are reflective of the general hospital pharmacy workforce across Australia, indicating that the results may be generalizable to the broader hospital pharmacy workforce. However, despite these strengths, the study also has some limitations. One limitation is that three of the factors that were identified from this study each only contain two items, which is less than the recommended minimum of three items. However, these items were previously single items in the original version of the survey and when combined together, produced a high factor loading with high internal reliability (Cronbach Alpha greater than 0.8). There are two possible ways to interpret these factors.
14 Firstly, they could be considered a unique factor based on high item factor loadings and high internal reliability. Alternatively, two split items could be viewed as repetitions of each other and as a result, produce very high internal consistency when they are brought back together in the confirmatory factor analysis. Future iterations of the survey, therefore, should contain more items to investigate these issues as they may be important issues specifically relevant to hospital pharmacy practice. The response rate for the survey was 27.4%, which is largely consistent with other Australian population based survey studies of pharmacists 32, 33 and provided a sample size sufficient for multivariate analyses. However, there is an inherent potential for non-response bias and, little is known about the demographic factors that can influence participants' perceptions of safety issues. Furthermore, the study participants were sourced from members of a professional body. A recent study has shown that those who have a professional membership rate more positively in patient safety culture profile studies 10 and hence, future work should aim to recruit participants with and without professional affiliations. Additionally, these data were collected in 2010 and since that time, there have been a number of industrial changes to the staffing levels and responsibilities of hospital pharmacists in Australia. Consequently, the analysis of this dataset and validation of the survey tool may provide a baseline for future studies to evaluate changes to patient safety climate that occurred as a result of the industrial changes.
Conclusion
This study has demonstrated the validity of a survey tool to evaluate patient safety climate of Australian hospital pharmacy staff using robust methodology. Importantly, the validated factor structure that was derived from the study can be used as a basis to undertake future work in evaluating changes in safety culture among hospital pharmacy staff over time. This is particularly useful as hospital administrators have expressed an interest in evaluating and potentially improving safety climate as part of their patient safety initiatives. Additionally, future work should place emphasis on examining the potential issues that may influence hospital pharmacy staff members' patient safety attitudes and their overall perceptions of the level of patient safety in their hospital department.
